4,120 reports of this reaction
6.5% of all NICOTINE POLACRILEX reports
#2 most reported adverse reaction
NICOTINE DEPENDENCE is the #2 most commonly reported adverse reaction for NICOTINE POLACRILEX, manufactured by Haleon US Holdings LLC. There are 4,120 FDA adverse event reports linking NICOTINE POLACRILEX to NICOTINE DEPENDENCE. This represents approximately 6.5% of all 62,946 adverse event reports for this drug.
NICOTINE POLACRILEX has an overall safety score of 78 out of 100. Patients taking NICOTINE POLACRILEX who experience nicotine dependence should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NICOTINE DEPENDENCE is moderately reported among NICOTINE POLACRILEX users, representing a notable but not dominant share of adverse events.
In addition to nicotine dependence, the following adverse reactions have been reported for NICOTINE POLACRILEX:
The following drugs have also been linked to nicotine dependence in FDA adverse event reports:
NICOTINE DEPENDENCE has been reported as an adverse event in 4,120 FDA reports for NICOTINE POLACRILEX. This does not prove causation, but indicates an association observed in post-market surveillance data.
NICOTINE DEPENDENCE accounts for approximately 6.5% of all adverse event reports for NICOTINE POLACRILEX, making it one of the most commonly reported side effect.
If you experience nicotine dependence while taking NICOTINE POLACRILEX, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.